Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

nyse:abbv

POPULAR ARTICLES

Health Canada Approves AbbVie's RINVOQ® for the Treatment of Adults with Active Non-Radiographic Axial Spondyloarthritis

Life Science Investing

Health Canada Approves AbbVie's RINVOQ® for the Treatment of Adults with Active Non-Radiographic Axial Spondyloarthritis

AbbVie Releases New Data Demonstrating Breadth of Its Gastroenterology Portfolio at 2023 Digestive Disease Week®

Life Science Investing

AbbVie Releases New Data Demonstrating Breadth of Its Gastroenterology Portfolio at 2023 Digestive Disease Week®

VIDEO - Marc Lichtenfeld: Short or Long Term, Know Why You’re in Gold

VIDEO - Marc Lichtenfeld: Short or Long Term, Know Why You’re in Gold

LATEST ARTICLES

AbbVie’s VENCLEXTA Gets Health Canada Approval to Treat CLL

AbbVie to Acquire Allergan in Blockbuster US$63 Billion Deal

Pharmaceutical Investing

AbbVie to Acquire Allergan in Blockbuster US$63 Billion Deal

Pharma Market Update: Q1 2019 in Review

Pharmaceutical Investing

Pharma Market Update: Q1 2019 in Review

NYSE:ABBV

Which Life Science IPOs is the Government Shutdown Affecting?

NASDAQ:AMGN

Abbvie’s Humira Faces Biosimilar Competition

NYSE:ABBV

AbbVie Notches FDA Approval for Endometriosis Pain Treatment

Latest News

Inca to Raise $1.1M

CONNEQT Launches Apple Health Integration on iPhone

Reconciled gold pour exceeds expectations

Group Eleven Welcomes Franz Bollmann to the Board of Directors

Blue Lagoon Continues to Strengthen Treasury to Fund Final Preparations of Mine Site and Initial Working Capital to Fund Commencement of Production